TY  - JOUR
AU  - Merchante, Nicolas
AU  - Carcel, Sheila
AU  - Garrido-Gracia, Jose Carlos
AU  - Trigo-Rodriguez, Marta
AU  - Esteban-Moreno, Maria Angeles 
AU  - Leon-Lopez, Rafael
AU  - Espindola-Gomez, Reinaldo
AU  - Aguilar-Alonso, Eduardo 
AU  - Vinuesa-Garcia, David 
AU  - Romero-Palacios, Alberto
AU  - Perez-Camacho, Ines
AU  - Gutierrez-Gutierrez, Belen
AU  - Martinez-Marcos, Francisco Javier
AU  - Fernandez-Roldan, Concepcion
AU  - Martinez-Perez-Crespo, Pedro Maria 
AU  - Aceituno-Caño, Alexandra 
AU  - Leon, Eva
AU  - Corzo, Juan E
AU  - de-la-Fuente, Carmen
AU  - Torre-Cisneros, Julian
PY  - 2021
DO  - 10.1128/AAC.02107-21
UR  - http://hdl.handle.net/10668/20033
T2  - Antimicrobial agents and chemotherapy
AB  - The objective of this study was to investigate the efficacy and safety of early treatment with sarilumab, added to standard of care (SOC), in hospitalized adults with COVID-19. Methods included phase II, open-label, randomized, controlled clinical...
LA  - en
PB  - American Society for Microbiology
KW  - SARS-CoV-2. COVID-19
KW  - Interleukin 6
KW  - Sarilumab
KW  - Tocilizumab
KW  - Area de Gestión Sanitaria Sur de Córdoba
KW  - Área de Gestión Sanitaria Sur de Sevilla
KW  - Adult
KW  - Antibodies, monoclonal, humanized
KW  - Humans
KW  - Inflammation
KW  - SARS-CoV-2
KW  - Treatment outcome
KW  - COVID-19 drug treatment
TI  - Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial.
TY  - research article
VL  - 66
ER  -